Analysis of the anemia characteristics in early pregnancy and outcomes of pregnant women with hemoglobin H disease
J.-Y. Su, Y. Chen, H.-F. Chen, J.-R. Tong, Y.-N. Wei, L.-L. Huang, L. Deng Department of Obstetrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. dengli@gxmu.edu.cn
OBJECTIVE: This study aimed to analyze the anemia characteristics in early pregnancy of pregnant women with hemoglobin H (Hb H) disease and their pregnancy outcomes, and to provide reference to the pregnancy management and treatment of these women.
PATIENTS AND METHODS: Twenty-eight cases of pregnant women who had been diagnosed with Hb H disease in the Second Affiliated Hospital of Guangxi Medical University from August 2018 to March 2022 were retrospectively analyzed. Moreover, 28 cases of normal pregnant women in the same period were randomly enrolled as a control group for comparison. The means and percentages of the anemia characteristics in early pregnancy and the pregnancy outcomes were calculated and the analysis of variance, Chi-square test, and Fisher’s exact test were applied for comparison.
RESULTS: A total of 13 cases of missing type (46.43%) and 15 cases of non-missing type (53.57%) were observed in the 28 cases of pregnant women with Hb H disease. The genotypes were as follows: 8 cases of −α3.7/–SEA (28.57%), 4 cases of −α4.2/–SEA (14.29%), 1 case of −α4.2/–THAI (3.57%), 9 cases of αCSα/–SEA (32.14%), 5 cases of αWSα/–SEA (17.86%), and 1 case of αQSα/–SEA (3.57%). Twenty-seven patients with Hb H disease (96.43%) were anemic, including 5 cases of mild anemia (17.86%), 18 cases of moderate anemia (64.28%), 4 cases of severe anemia (14.29%), and 1 case of non-anemia (3.57%). Compared with the control group, the Hb H group had significantly higher red blood cell count and significantly lower Hb, mean corpuscular volume, and mean corpuscular hemoglobin, and the differences were statistically significant (p < 0.05). The Hb H group had higher incidence rates of blood transfusion during pregnancy (BTDP), oligohydramnios fetal growth restrictions (FGR), and fetal distress than the control group. The weights of neonates were lower in the Hb H group than in the control group. Statistically significant differences were found between these two groups (p < 0.05).
CONCLUSIONS: The genotype missing type of pregnant women with Hb H disease was mainly −α3.7/–SEA and the non-missing type was mainly αCSα/–SEA. Hb H disease can easily cause various degrees of anemia (mainly moderate anemia in this study). Moreover, it can increase the incidence rate of pregnancy complications such as BTDP, oligohydramnios, FGR, and fetal distress, which will reduce the weight of neonates and seriously affect maternal and infant safety. Therefore, maternal anemia and fetal growth and development should be monitored during pregnancy and delivery, and transfusion therapy should be used to improve adverse pregnancy outcomes caused by anemia when necessary.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J.-Y. Su, Y. Chen, H.-F. Chen, J.-R. Tong, Y.-N. Wei, L.-L. Huang, L. Deng
Analysis of the anemia characteristics in early pregnancy and outcomes of pregnant women with hemoglobin H disease
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 3
Pages: 1027-1032
DOI: 10.26355/eurrev_202302_31198